loadpatents
name:-0.061342000961304
name:-0.032159090042114
name:-0.00046300888061523
Dinges; Jurgen Patent Filings

Dinges; Jurgen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dinges; Jurgen.The latest application filed is for "substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use".

Company Profile
0.32.51
  • Dinges; Jurgen - North Chicago IL
  • Dinges; Jurgen - Wadsworth IL
  • Dinges; Jurgen - Abbott Park IL
  • Dinges; Jurgen - Grayslake IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
Grant 10,556,914 - Dinges , et al. Feb
2020-02-11
Substituted Isoxazolopyridazinones And Isothiazolopyridazinones And Methods Of Use
App 20190367531 - DINGES; Jurgen ;   et al.
2019-12-05
Inhibitor compounds of phosphodiesterase type 10A
Grant 10,308,610 - Geneste , et al.
2019-06-04
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20180222905 - Geneste; Herve ;   et al.
2018-08-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20180099936 - Geneste; Herve ;   et al.
2018-04-12
Inhibitor compounds of phosphodiesterase type 10A
Grant 9,938,269 - Geneste , et al. April 10, 2
2018-04-10
Inhibitor compounds of phosphodiesterase type 10A
Grant 9,856,220 - Geneste , et al. January 2, 2
2018-01-02
Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors
Grant 9,657,034 - Geneste , et al. May 23, 2
2017-05-23
Substituted Isoxazolopyridazinones And Isothiazolopyridazinones And Methods Of Use
App 20170073353 - DINGES; Jurgen ;   et al.
2017-03-16
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20160318871 - Geneste; Herve ;   et al.
2016-11-03
Inhibitor compounds of phosphodiesterase type 10A
Grant 9,475,808 - Geneste , et al. October 25, 2
2016-10-25
Treatment of central nervous system disorders
Grant 9,464,072 - Bitner , et al. October 11, 2
2016-10-11
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
Grant 9,388,148 - Haupt , et al. July 12, 2
2016-07-12
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
Grant 9,388,141 - Haupt , et al. July 12, 2
2016-07-12
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
Grant 9,376,396 - Haupt , et al. June 28, 2
2016-06-28
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20160137668 - GENESTE; Herve ;   et al.
2016-05-19
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 9,290,444 - Bitner , et al. March 22, 2
2016-03-22
Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A
Grant 9,273,068 - Geneste , et al. March 1, 2
2016-03-01
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20160002231 - GENESTE; Herve ;   et al.
2016-01-07
Inhibitor compounds of phosphodiesterase type 10A
Grant 9,200,005 - Jantos , et al. December 1, 2
2015-12-01
Inhibitor compounds of phosphodiesterase type 10A
Grant 9,163,019 - Geneste , et al. October 20, 2
2015-10-20
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme
App 20150265613 - Bitner; R. Scott ;   et al.
2015-09-24
Treatment Of Central Nervous System Disorders
App 20150099740 - Bitner; R. Scott ;   et al.
2015-04-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 8,993,632 - Bitner , et al. March 31, 2
2015-03-31
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme
App 20150065508 - Bitner; R. Scott ;   et al.
2015-03-05
Treatment of central nervous system disorders
Grant 8,940,902 - Bitner , et al. January 27, 2
2015-01-27
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor
App 20140303176 - HAUPT; Andreas ;   et al.
2014-10-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20140303153 - GENESTE; Herve ;   et al.
2014-10-09
Novel inhibitor compounds of phosphodiesterase type 10A
App 20140275069 - JANTOS; Katja ;   et al.
2014-09-18
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor
App 20140275104 - HAUPT; Andreas ;   et al.
2014-09-18
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 8,716,345 - Bitner , et al. May 6, 2
2014-05-06
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20130116229 - Geneste; Herve ;   et al.
2013-05-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20130116241 - Geneste; Herve ;   et al.
2013-05-09
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20130116233 - Geneste; Herve ;   et al.
2013-05-09
Treatment Of Central Nervous System Disorders
App 20130059829 - Bitner; R. Scott ;   et al.
2013-03-07
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme
App 20130045978 - Bitner; R. Scott ;   et al.
2013-02-21
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a
App 20130005705 - Geneste; Herve ;   et al.
2013-01-03
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
App 20120289512 - Bitner; R. Scott ;   et al.
2012-11-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 8,198,331 - Bitner , et al. June 12, 2
2012-06-12
N-acylsulfonamide apoptosis promoters
Grant 7,754,886 - Augeri , et al. July 13, 2
2010-07-13
Treatment Of Central Nervous System Disorders
App 20100152179 - Bitner; R. Scott ;   et al.
2010-06-17
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
Grant 7,671,076 - Akritopoulou-Zanze , et al. March 2, 2
2010-03-02
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme
App 20090192198 - Bitner; R. Scott ;   et al.
2009-07-30
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme
App 20090176783 - Bitner; R. Scott ;   et al.
2009-07-09
N-acylsulfonamide Apoptosis Promoters
App 20090137585 - Augeri; David J. ;   et al.
2009-05-28
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 7,528,282 - Rohde , et al. May 5, 2
2009-05-05
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 7,511,175 - Patel , et al. March 31, 2
2009-03-31
N-acylsulfonamide apoptosis promoters
Grant 7,504,512 - Augeri , et al. March 17, 2
2009-03-17
Treatment Of Central Nervous System Disorders
App 20090054426 - Bitner; R. Scott ;   et al.
2009-02-26
Tricyclic pyrazole kinase inhibitors
Grant 7,468,371 - Arnold , et al. December 23, 2
2008-12-23
Pharmaceutical Compositions As Inhibitors Of Dipeptidyl Peptidase-iv (dpp-iv)
App 20080119464 - Akritopoulou-Zanze; Irini ;   et al.
2008-05-22
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
Grant 7,348,346 - Akritopoulou-Zanze , et al. March 25, 2
2008-03-25
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme
App 20070179186 - Rohde; Jeffrey J. ;   et al.
2007-08-02
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Grant 7,217,838 - Rohde , et al. May 15, 2
2007-05-15
Method Of Inhibiting Angiogenesis
App 20070043089 - HAVIV; FORTUNA ;   et al.
2007-02-22
Method Of Inhibiting Angiogenesis
App 20070032527 - Haviv; Fortuna ;   et al.
2007-02-08
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
App 20060281773 - Patel; Jyoti R. ;   et al.
2006-12-14
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
App 20060149070 - Rohde; Jeffrey J. ;   et al.
2006-07-06
Substituted pyridines having antiangiogenic activity
App 20060030557 - Haviv; Fortuna ;   et al.
2006-02-09
Tricyclic pyrazole kinase inhibitors
App 20060014816 - Arnold; Lee D. ;   et al.
2006-01-19
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
App 20050215603 - Akritopoulou-Zanze, Irini ;   et al.
2005-09-29
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
App 20050209249 - Akritopoulou-Zanze, Irini ;   et al.
2005-09-22
Kinase inhibitors
Grant 6,831,175 - Li , et al. December 14, 2
2004-12-14
N-acylsulfonamide apoptosis promoters
App 20040192681 - Augeri, David J. ;   et al.
2004-09-30
Method of inhibiting angiogenesis
App 20040116479 - Haviv, Fortuna ;   et al.
2004-06-17
N-acylsulfonamide apoptosis promoters
Grant 6,720,338 - Augeri , et al. April 13, 2
2004-04-13
Method of inhibiting angiogenesis
App 20040067985 - Haviv, Fortuna ;   et al.
2004-04-08
Substituted pyridines having antiangiogenic activity
App 20040014744 - Haviv, Fortuna ;   et al.
2004-01-22
Kinase inhibitors
App 20030199511 - Li, Qun ;   et al.
2003-10-23
Substituted pyridines having antiangiogenic activity
App 20030195195 - Haviv, Fortuna ;   et al.
2003-10-16
Kinase inhibitors
App 20030187026 - Li, Qun ;   et al.
2003-10-02
Aminal diones as potassium channel openers
App 20020165264 - Kort, Michael E. ;   et al.
2002-11-07
Aminal Diones as potassium channel openers
App 20020147230 - Kort, Michael E. ;   et al.
2002-10-10
N-Acylsulfonamide apoptosis promoters
App 20020086887 - Augeri, David J. ;   et al.
2002-07-04
N-acylsulfonamide apoptosis promoters
App 20020055631 - Augeri, David J. ;   et al.
2002-05-09
Quinoline and naphthyridine carboxylic acid antibacterials
App 20020049223 - Elmore, Steven W. ;   et al.
2002-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed